Portfolio company
NXThera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops water vapour therapy systems to treat patients suffering from enlarged prostate and prostate cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Francis Medical
This company develops water vapor ablation systems used by physicians to treat prostate, kidney and bladder cancers.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
ProVerum
This company develops minimally invasive nitinol stents to treat benign prostatic hyperplasia in male patients.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
ProVerum Medical
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
Alessa Therapeutics
This company develops a drug-delivery platform for the localized release of therapies to treat patients with early-stage prostate cancer.
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.